CABF Pepsi Project Fundraiser: Scientific Advisory Kiki Chang received money from drug companies

CABF-bpkids , A parent support organization for children with bipolar & depression and other psychiatric labels. The organization is heavily reliant upon drug company paid and influenced KOL's (Key Opinion Leaders) The organization plays a risky card game when having conflicted doctors on their advisory boards. The direct influence of his pharma income and the drugs used to treat kids with mental illness is in fact a bitter pill to swallow ethically.

Scientific Advisory Council:

Featuring

Kiki Chang, M.D.

Associate Professor and Director of Pediatric Bipolar Disorders Program, Child and Adolescent Psychiatry, Stanford University School of Medicine in Palo Alto, California

Medscape:

Bipolar Disorders and Genetics: Early Detection of Bipolar Disorder


Authors and Disclosures

"Kiki D. Chang, MD, Assistant Professor, Stanford University, Stanford, California; Director, Pediatric Bipolar Disorders Program, Lucile Packard Children's Hospital, Palo Alto, California

Kim A. Gallelli, PhD, Postdoctoral Fellow, Department of Psychiatry & Behavioral Sciences, Stanford University School of Medicine, Stanford, California; Postdoctoral Fellow, Department of Psychiatry & Behavioral Sciences, Stanford University Medical Center, Stanford, California.

Disclosure: Kiki D. Chang, MD, has disclosed he served as a consultant for Abbott Laboratories, AstraZeneca, Eli Lilly & Company, GlaxoSmithKline, Janssen Pharmaceutica, Shire US, and UCB Pharma. He receives research support from Abbott Laboratories, GlaxoSmithKline, National Institute of Mental Health, Heinz C. Prechter Foundation, National Alliance for Research in Schizophrenia and Depression, and the Klingenstein Third Generation Foundation.

He also reports he serves on the speakers' bureau for Abbott Laboratories, AstraZeneca, Eli Lilly & Company, GlaxoSmithKline, and Ortho-McNeil. Dr. Chang also reports he discusses the unlabeled use of psychotropic medication in children less than 18 years of age.

Disclosure: Kim A Gallelli, PhD, has no significant financial interests or relationships to disclose. "

---
When a doctor is a scientific advisory council member of a support organization for parents with bipolar and depression and other psychiatric labels, and receives income from the drug companies that sell the drugs to treat those psychiatric diagnosis one MUST question the integrity and the ethics of such a direct influence into the treatment of these children.

Abbott-makers of Depakote --mood stabilizer
AstraZeneca-makers of Seroquel--antipsychotic and antipsychotic promoted for use for depression
GlaxoSmithKline--makers of Paxil--antidepressant
Eli Lilly-makers of Zyprexa--antipsychotic

When Dr. Chang discusses treatment protocol and these drugs, there is COI--Conflict of Interest.